Klinické štúdie Lupus v štáte New York
26 štúdií pre Lupus hľadá účastníkov v zariadeniach v štáte New York.
Mestá v štáte New York
Oficiálny text štúdie (anglicky)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50010, Brooklyn
- Sl0044 50264, Manhasset
- Sl0044 50077, New York
- a 1 ďalších
Prebieha náborFáza 3
Vek 16 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
Prebieha náborFáza 2
Vek 18 až 100 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05268289An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Hyde Park
- Research Site, New York
- Research Site, The Bronx
- a 1 ďalších
Prebieha náborFáza 3
Vek 5 až 17 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05835310Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- a 1 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
Prebieha náborFáza 2
Vek 16 až 70 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
- Feinstein Institutes for Medical Research, Manhasset
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06987565HEALTH Home Urinalysis Testing
- NYU Langone Health, New York
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07823478A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
Prebieha náborFáza 1/2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 1
Vek 18 až 74 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07085104A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- New York University School Of Medicine, New York
Prebieha náborFáza 4
Vek 18 až 75 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Kings County Hospital Center - Brooklyn, Brooklyn
Prebieha náborObservačná štúdia
Vek 16 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
Prebieha náborFáza 1/2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
Prebieha náborFáza 2
Vek 12 až 65 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT07053800A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06570798Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- a 2 ďalších
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Fairport
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07260877Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 7. 2026 · NCT07138898Trial of Belimumab in Early Lupus
- Feinstein Institute, Manhasset
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT03543839A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Prebieha náborFáza 1
Vek 18 až 70 · Všetky pohlavia · Aktualizované 5. 6. 2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US08-0, Syracuse
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 až 70 · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
Prebieha náborFáza 1
Vek 12 až 70 · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06308978Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 až 45 · Ženy · Aktualizované 28. 4. 2026 · NCT00198068Alnuctamab for Refractory SLE (LATTE Study)
- Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 1
Vek 18 až 60 · Všetky pohlavia · Aktualizované 21. 4. 2026 · NCT07219563Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- a 1 ďalších
Prebieha náborObservačná štúdia
Vek 18 až 110 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT05934149Safety of the Herpes Zoster Subunit Vaccine in Lupus
- NYU Langone Health, New York
Prebieha náborFáza 4
Vek 18 až 90 · Všetky pohlavia · Aktualizované 26. 12. 2025 · NCT05559671Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
Prebieha náborSkorá fáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 11. 2025 · NCT07107659Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.